DMARDs and the JAK Inhibitors have improved RA treatment. But not many new drugs are in the offing at the moment.
New point-of-care tools offer greater transparency.
A look at the president and CEO's experience in becoming an influential reason for Intermountain Healthcare's success.
How two hospitals and two insurers are working to turn the tide of the opioid epidemic.
Managed Healthcare Executive asked thought leaders: “What apps do you use the most on your phone?” Here’s what they said.
While it is a common understanding that too much of the $3.6 trillion we spend on healthcare is not wisely spent, there are opportunities for the industry to make some changes.
There is fairly broad agreement that conditions like cancer, diabetes, and more will be the most costly for the American healthcare system over the next decade.
Medicare Advantage plans are now covering more benefits than they have in the past for those facing social determinants of health in their daily lifestyles.
The successor, Oncology Care First, will likely include two tracks with downside risk right from the start.